Bosakitug is a Potential Best-in-Class Investigational Monoclonal Antibody with Demonstrated Superior Potency, Residence Time ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product ...

WAYNE, Pa. - Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company with a market capitalization of $158 million, announced today the commencement of a Phase 2 trial ...

WAYNE, Pa. - Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company with a market capitalization of $158 million, announced today the commencement of a Phase 2 trial for ...

Fintel reports that on May 28, 2025, Wedbush initiated coverage of Aclaris Therapeutics (NasdaqGS:ACRS) with a Outperform ...

Ahmedabad: Intas Pharma has announced the appointment of Amit Modi as Associate Vice President - Supply Chain Management.The ...

WAYNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for ...

The Business Research Company’s General Anesthesia Drugs Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /EINPresswire.com/ ...

Detailed price information for Aclaris Therapts (ACRS-Q) from The Globe and Mail including charting and trades.

Baxter said the Ahmedabad R&D centre will help the company to accelerate innovation in generic and differentiated injectable pharmaceuticals. "The Boards of Directors of both companies have approved ...